INTERNATIONAL NEWS

Germany, France, Itally and Spain has topped the covid-19 vaccination

Germany, France, Itally and Spain has topped the covid-19 vaccination

Germany, France, Itally and Spain have stopped the covid-19 vaccination

The World Health Organization (WHO) has urged countries not to pause Covid vaccinations, as several major EU member states halted their rollouts of the Oxford-AstraZeneca jab.

It said there was no evidence of a link between the vaccine and blood clots.

However, Germany, France, Italy and Spain joined smaller nations in halting vaccinations as a precaution while checks are made.

The WHO’s vaccine safety experts are meeting on Tuesday to discuss the jab

The European Medicines Agency (EMA) will meet on the same day and is due to draw conclusions on Thursday. It has also said the vaccine should continue to be used.

There have been a number of cases in Europe of blood clots developing after the vaccine was administered.

So far, Germany, France, Itally and Spain has topped the covid-19 vaccination.

However, experts say these were no more than the number of blood-clot incidents typically reported within the general population.

About 17 million people in the EU and the UK have received a dose of the vaccine, with fewer than 40 cases of blood clots reported as of last week, AstraZeneca said.

Germany’s health ministry announced on Monday that it would stop administering the Oxford-AstraZeneca vaccine with immediate effect, on the recommendation of the Paul Ehrlich Institute (PEI), the country’s authority on vaccines.

READ ALSOI will not serve the interest of any party, not even my girlfriend, i am serving Ghana —Speaker of parliament

“The background to this decision follows new reports of cases of cerebral vein thrombosis connected with an AstraZeneca vaccination,” Health Minister Jens Spahn said.

“In light of these newly reported cases, the Paul Ehrlich Institute today re-evaluated the situation and recommended a suspension of vaccinations and further analysis.”

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close
Close